Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Datasets
Search by expertise, name or affiliation
Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women
William J. Gradishar
*
*
Corresponding author for this work
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Review article
›
peer-review
27
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
INIS
assessments
11%
breasts
44%
cancer
55%
comparative evaluations
55%
data
33%
diseases
11%
hormones
22%
patients
11%
receptors
11%
risks
11%
safety
55%
side effects
11%
tamoxifen
100%
therapy
66%
women
33%
Pharmacology, Toxicology and Pharmaceutical Science
Absence
11%
Adverse Event
11%
Anastrozole
55%
Aromatase Inhibitor
11%
Breast Cancer
44%
Disease Free Survival
11%
Endocrine Therapy
22%
Endometrium Cancer
11%
Exemestane
22%
Hormone
11%
Hormone Receptor
11%
Letrozole
22%
Placebo
11%
Side Effect
11%
Tamoxifen
100%
Thromboembolism
11%
Tolerability
11%